Literature DB >> 13712620

Treatment of petit mal with ethosuximide.

K W HEATHFIELD, E C JEWESBURY.   

Abstract

Entities:  

Keywords:  ANTICOAGULANTS/therapy; EPILEPSY/therapy

Mesh:

Substances:

Year:  1961        PMID: 13712620      PMCID: PMC1969471          DOI: 10.1136/bmj.2.5251.565

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  A new drug for petit mal epilepsy.

Authors:  F T ZIMMERMAN; B B BURGEMEISTER
Journal:  Neurology       Date:  1958-10       Impact factor: 9.910

2.  Treatment of epilepsy with alpha-ethyl-alpha-methyl-succinimide (P.M. 671).

Authors:  N GORDON
Journal:  Neurology       Date:  1961-03       Impact factor: 9.910

3.  Experiences with alpha-ethyl-alpha-methylsuccinimide in the treatment of epilepsy.

Authors:  A M LORENTZ DE HAAS; L M STOEL
Journal:  Epilepsia       Date:  1960-06       Impact factor: 5.864

4.  [Anticonvulsant effect of succinimides].

Authors:  R VOSSEN
Journal:  Dtsch Med Wochenschr       Date:  1958-07-18       Impact factor: 0.628

  4 in total
  5 in total

1.  TREATMENT OF PETIT MAL WITH ETHOSUXIMIDE: FOLLOW-UP REPORT.

Authors:  K W HEATHFIELD; E C JEWESBURY
Journal:  Br Med J       Date:  1964-09-05

2.  ANTICONVULSANTS.

Authors:  A PHILLIPS
Journal:  Br Med J       Date:  1963-10-12

Review 3.  Psychiatric aspects of epilepsy.

Authors:  D F Scott
Journal:  Postgrad Med J       Date:  1968-04       Impact factor: 2.401

4.  Drug treatment of epilepsy.

Authors: 
Journal:  Br Med J       Date:  1968-05-11

5.  Targeting Neural Synchrony Deficits is Sufficient to Improve Cognition in a Schizophrenia-Related Neurodevelopmental Model.

Authors:  Heekyung Lee; Dino Dvorak; André A Fenton
Journal:  Front Psychiatry       Date:  2014-02-14       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.